Michael Ambrogi
2018
In 2018, Michael Ambrogi earned a total compensation of $2.6M as Chief Operating Officer at NovoCure, a 16% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $243,750 |
|---|---|
| Option Awards | $1,572,930 |
| Salary | $390,000 |
| Stock Awards | $391,677 |
| Other | $13,350 |
| Total | $2,611,707 |
Ambrogi received $1.6M in option awards, accounting for 60% of the total pay in 2018.
Ambrogi also received $243.8K in non-equity incentive plan, $390K in salary, $391.7K in stock awards and $13.4K in other compensation.
Rankings
In 2018, Michael Ambrogi's compensation ranked 4,470th out of 14,244 executives tracked by ExecPay. In other words, Ambrogi earned more than 68.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,470 out of 14,244 | 69th |
Division Manufacturing | 1,675 out of 5,765 | 71st |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 213 out of 849 | 75th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 117 out of 547 | 79th |
Industry Surgical and Medical Instruments and Apparatus | 75 out of 348 | 78th |
Source: SEC filing on April 27, 2020.
Ambrogi's colleagues
We found five more compensation records of executives who worked with Michael Ambrogi at NovoCure in 2018.